Table of contents
Volume 98, Issue 5
Published online 4 March 2008 (857-1020)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Book Review
Minireview
Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
C Lemos, G Jansen and G J Peters
Br J Cancer 98: 857-862; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604213
Clinical Studies
Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening
Y-K Huang, S-L You, C-C Yuan, Y-M Ke, J-M Cao, C-Y Liao, C-H Wu, C-S Hsu, K-F Huang, C-H Lu, N-F Twu and T-Y Chu
Br J Cancer 98: 863-869; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604262
Second malignancies after breast cancer: the impact of different treatment modalities
Y M Kirova, Y De Rycke, L Gambotti, J-Y Pierga, B Asselain and A Fourquet for the Institut Curie Breast Cancer Study Group
Br J Cancer 98: 870-874; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604241
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer
I Sobhani, E Tiret, R Lebtahi, T Aparicio, E Itti, F Montravers, C Vaylet, P Rougier, T André, J M Gornet, D Cherqui, C Delbaldo, Y Panis, J N Talbot, M Meignan and D Le Guludec
Br J Cancer 98: 875-880; advance online publication, February 26, 2008; doi:10.1038/sj.bjc.6604263
Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
S P Hong, J Y Park, T J Jeon, S Bang, S W Park, J B Chung, M-S Park, J Seong, W J Lee and S Y Song
Br J Cancer 98: 881-887; advance online publication, February 26, 2008; doi:10.1038/sj.bjc.6604247
The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer
M McKernan, D C McMillan, J R Anderson, W J Angerson and R C Stuart
Br J Cancer 98: 888-893; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604248
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
S P Blagden, L R Molife, A Seebaran, M Payne, A H M Reid, A S Protheroe, L S Vasist, D D Williams, C Bowen, S J Kathman, J P Hodge, M M Dar, J S de Bono and M R Middleton
Br J Cancer 98: 894-899; doi:10.1038/sj.bjc.6604264
Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer development
K Kuester, A Kovar, C Lüpfert, B Brockhaus and C Kloft
Br J Cancer 98: 900-906; doi:10.1038/sj.bjc.6604265
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, S Negoro, T Hirashima, S Kudoh, Y Ichinose, N Ebi, K Shibata, T Nishimura, N Katakami, T Sawa, E Shimizu, J Fukuoka, T Satoh and M Fukuoka
Br J Cancer 98: 907-914; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604249
Translational Therapeutics
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant
Y Shimizu, I Kinoshita, J Kikuchi, K Yamazaki, M Nishimura, M J Birrer and H Dosaka-Akita
Br J Cancer 98: 915-922; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604267
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
R Bianco, S Garofalo, R Rosa, V Damiano, T Gelardi, G Daniele, R Marciano, F Ciardiello and G Tortora
Br J Cancer 98: 923-930; doi:10.1038/sj.bjc.6604269
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma
L Campbell, B Jasani, K Edwards, M Gumbleton and D F R Griffiths
Br J Cancer 98: 931-940; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604243
Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis
V Bilim, K Yuuki, T Itoi, A Muto, T Kato, A Nagaoka, T Motoyama and Y Tomita
Br J Cancer 98: 941-949; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604268
Molecular Diagnostics
Cortactin expression predicts poor survival in laryngeal carcinoma
J H Gibcus, M F Mastik, L Menkema, G H de Bock, Ph M Kluin, Ed Schuuring and J E van der Wal
Br J Cancer 98: 950-955; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604246
Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
P Hofman, C Butori, K Havet, V Hofman, E Selva, N Guevara, J Santini and E Van Obberghen-Schilling
Br J Cancer 98: 956-964; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604245
Hypoxia-associated markers in gastric carcinogenesis and HIF-2
in gastric and gastro-oesophageal cancer prognosis
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine, P M Price, I M Welch and C M L West
Br J Cancer 98: 965-973; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604210
Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation
Y Baba, K-i Iyama, K Hirashima, Y Nagai, N Yoshida, N Hayashi, N Miyanari and H Baba
Br J Cancer 98: 974-980; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604252
Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation
C P Christov, E Trivier and T Krude
Br J Cancer 98: 981-988; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604254
Epidemiology
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
S M Zhang, N R Cook, J E Manson, I-M Lee and J E Buring
Br J Cancer 98: 989-991; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604240
Parity and breastfeeding are protective against breast cancer in Nigerian women
D Huo, C A Adebamowo, T O Ogundiran, E E Akang, O Campbell, A Adenipekun, S Cummings, J Fackenthal, F Ademuyiwa, H Ahsan and O I Olopade
Br J Cancer 98: 992-996; advance online publication, February 26, 2008; doi:10.1038/sj.bjc.6604275
Association of colorectal adenoma with other malignancies in Swedish families
E Hiripi, J Lorenzo Bermejo, J Sundquist and K Hemminki
Br J Cancer 98: 997-1000; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604276
Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
A Andersson, G Enblad, B Tavelin, M Björkholm, J Linderoth, I Lagerlöf, M Merup, M Sender and B Malmer
Br J Cancer 98: 1001-1005; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604244
Population mixing, socioeconomic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales: analysis by census ward
C A Stiller, M E Kroll, P J Boyle and Z Feng
Br J Cancer 98: 1006-1011; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604237
Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe
G Menvielle, A E Kunst, I Stirbu, B H Strand, C Borrell, E Regidor, A Leclerc, S Esnaola, M Bopp, O Lundberg, B Artnik, G Costa, P Deboosere, P Martikainen and J P Mackenbach
Br J Cancer 98: 1012-1019; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604274
Book Review
Radiation Oncology Physics: A Handbook for Teachers and Students
I Rosenberg
Br J Cancer 98: 1020; doi:10.1038/sj.bjc.6604224
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.